Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial
- 31 July 2007
- journal article
- research article
- Published by Wiley in Transfusion Medicine
- Vol. 17 (4) , 285-289
Abstract
summary Despite the refinements in surgical technique, rates of homologous blood transfusion (HBT) in cardiac surgery remain high. The adverse effects of blood transfusion are well documented. Retransfusion of shed mediastinal blood reduces the requirement for HBTs during conventional coronary artery bypass grafting. However, some studies have found that autotransfusion leads to bleeding diathesis and paradoxical increase in blood transfusions. Through this prospective randomized trial, we have studied the safety and efficacy of this modality in patients undergoing off‐pump coronary artery bypass grafting (OPCAB). Fifty patients enrolled in the study and 49 fulfilled the study criteria. They were randomly divided into group C (cell saver) and group N (non‐cell saver). Whereas the cell saver group received processed shed autologous blood and homologous blood if necessary, the non‐saver group was transfused homologous blood only. The threshold for transfusion was haemoglobin of 9 g dL−1 in both the groups. The cell saver group required significantly less number of HBTs (1·6 ± 1·2 vs. 2·4 ± 1·3 units). The incidence of re‐exploration was zero in both the groups. The mean mediastinal drainage in both the groups was not significantly different (355 ± 196 vs. 316 ± 119·8 mL). The number of patients requiring any blood transfusion however was very high. All the patients in the non‐saver group and 20 (83%) of the patients in the saver group received homologous blood. During OPCAB surgery, the use of cell saver reduced the requirement for HBT. Its use is not associated with any clinically significant bleeding diathesis.Keywords
This publication has 18 references indexed in Scilit:
- Clopidogrel and Bleeding After Coronary Artery Bypass Graft SurgeryThe Annals of Thoracic Surgery, 2005
- Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgeryEuropean Journal of Cardio-Thoracic Surgery, 2005
- Does Clopidogrel Increase Blood Loss Following Coronary Artery Bypass Surgery?The Annals of Thoracic Surgery, 2004
- Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trialThe Annals of Thoracic Surgery, 2004
- Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: The effects of the type of transfused red blood cell product and surgical settingTransfusion Medicine Reviews, 2002
- Nosocomial pneumonia in patients undergoing heart surgeryCritical Care Medicine, 2000
- Adverse Effects of Postoperative Infusion of Shed Mediastinal BloodThe Annals of Thoracic Surgery, 1996
- Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusionThe Annals of Thoracic Surgery, 1996
- Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasisThe Annals of Thoracic Surgery, 1995
- Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass techniquePerfusion, 1994